Vitamin D and inflammatory bowel disease: Chicken or egg?

Inflammatory Bowel Diseases

Volumn 19, Issue 2, 2013, Pages 459-460

  Ananthakrishnan, A N ^c   Khalili, H ^c   Higuch, L M ^c   Hart, Ailsa L ^a,b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; IMMUNOMODULATING AGENT; PLACEBO; VITAMIN D;

CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; FAMILY HISTORY; HUMAN; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY;

EID: 84876416293     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.23031     Document Type: Note

References (11)

1. Ananthakrishnan AN, Khalili H, Higuch LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. March 2012;143:482-489.
2. Kotsopoulos J, Tworoger SS, Campos H, et al. Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev. 2010;19:938-946.
3. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:1-20.
4. Joseph AJ, George B, Pulimood AB, et al. 25(OH) Vitamin D level in Crohn's disease association with sun exposure and disease activity. Indian J Med Res. 2009;130:133-137.
5. Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 2007;30;8:5.
6. Cantorna MT, Munsick C, Bemiss C, et al. 1, 25-dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine IBD. J Nutr. 2000; 130:2648-2652.
7. Daniel C, Sartory NA, Zahn N, et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 2008;324: 23-33.
8. Jørgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther. 2010;32: 377-383.
9. Wang TT, Dabbas B, Laperriere D, et al. Direct and indirect induction by 1, 25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem. 2010;285: 2227-2231.
10. Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe. 2009;6:231-243.
11. Xystrakis E, Kusumakar S, Boswell S, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest. 2006;116:146-155.